Frank J. Riske
Frank J. Riske publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #2,670,534 of 7,710,434 ranked researchers
- Rank in United States
- #780,261 of 1,627,098
- Works
- 23
- Citations
- 1.1k
- Citations per work
- 47.4
What does Frank J. Riske research?
Frank J. Riske's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (12%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1354.7%
- Everything else521.8%
- Health Sciences312.5%
- Medicine312.5%
- Physical Sciences311.0%
- Engineering16.3%
- Chemistry14.7%
- 1Molecular Biology42% of their works
- 2Radiology, Nuclear Medicine and Imaging12% of their works
- 3Immunology8% of their works
- 4Biomedical Engineering6% of their works
- 5Biotechnology5% of their works
- 6Analytical Chemistry5% of their works
Research topics
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Enzyme Production and Characterization
- Glycosylation and Glycoproteins Research
- Chromatography in Natural Products
- Biofuel production and bioconversion
- Milk Quality and Mastitis in Dairy Cows
Which keywords describe Frank J. Riske's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Mammalian Cells, Protein Aggregation, Recombinant Protein and Antibody Engineering.
- Bovine Mastitis
- Natural Product Isolation
- Glycans
- Counter-Current Chromatography
- Biotechnological Applications
- Antibody Engineering
- Protein Aggregation
- Biopharmaceuticals
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Mammalian Cells
- Recombinant Protein
- Fc Receptors
- Cancer
- Enzymatic Hydrolysis
- Microbial Enzymes
- Pretreatment
- Milk Quality
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Glycosylation223 topics
- Monoclonal Antibodies192 topics
- Therapeutic Antibodies192 topics
- Biopharmaceuticals111 topic
- Mammalian Cells111 topic
- Protein Aggregation111 topic
- Recombinant Protein111 topic
- Antibody Engineering81 topic
- Fc Receptors81 topic
- Biotechnological Applications31 topic
- Cancer31 topic
- Counter-Current Chromatography31 topic
- Enzymatic Hydrolysis31 topic
- Glycans31 topic
- Microbial Enzymes31 topic
- Natural Product Isolation31 topic
- Pretreatment31 topic
- Bovine Mastitis11 topic
- Milk Quality11 topic
Where does Frank J. Riske work?
Frank J. Riske's main affiliation in the publication record is SynZyme Technologies (United States), United States.
How many publications and citations does Frank J. Riske have?
OpenAlex counts 23 works and 1,090 citations for Frank J. Riske, an h-index of 10, ranking #2,670,534 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frank J. Riske. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.